Open-label 24-month study of injectable extended-release naltrexone (XR-NTX) in healthcare professionals with opioid dependence

Read abstract ›

2018 Steering Committee Meeting

Stay in the loop!

Sign up to stay up to date with current content, news and events.

Sign up now